Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some new positive inotropic agents.

K E Andersson

    Acta Medica Scandinavica. Supplementum
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    New positive inotropic agents for congestive heart failure (CHF) show initial promise but lack long-term efficacy. Both adrenoceptor agonists and phosphodiesterase inhibitors require further study for sustained CHF treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Release of atrial natriuretic peptide during pulmonary artery clamping in man.

    Clinical physiology (Oxford, England)·1997
    Same author

    [Calcium antagonists. Great tissue selectivity is the basis of their therapeutic use].

    Lakartidningen·1997
    Same author

    Neurotransmitter release evoked by alpha-latrotoxin in the smooth muscle of the female pig urethra.

    Naunyn-Schmiedeberg's archives of pharmacology·1997
    Same author

    NANC transmitters in the female pig urethra--localization and modulation of release via alpha 2-adrenoceptors and potassium channels.

    British journal of pharmacology·1997
    Same author

    Morphological relations between haem oxygenases, NO-synthase and VIP in the canine and feline gastrointestinal tracts.

    Journal of the autonomic nervous system·1997
    Same author

    Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical study.

    British journal of pharmacology·1997

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Congestive heart failure (CHF) treatment seeks effective positive inotropic agents.
    • Current research focuses on adrenoceptor agonists and phosphodiesterase inhibitors.
    • Both drug classes aim to increase intracellular cyclic AMP for positive inotropic effects.

    Purpose of the Study:

    • To evaluate the efficacy of adrenoceptor agonists and phosphodiesterase inhibitors in treating congestive heart failure.
    • To assess the long-term effectiveness and potential detrimental effects of these agents on myocardial function.

    Main Methods:

    • Review of existing studies on adrenoceptor agonists (e.g., dopamine, dobutamine) and phosphodiesterase inhibitors (e.g., milrinone, amrinone) in CHF patients.
    • Analysis of short-term and long-term treatment outcomes, including cardiac performance and potential adverse effects.

    Related Experiment Videos

    Main Results:

    • Adrenoceptor agonists provide initial benefits in CHF but appear ineffective for long-term treatment, possibly due to receptor desensitization.
    • Phosphodiesterase inhibitors demonstrate short-term improvements in cardiac performance in CHF patients.
    • Long-term results for phosphodiesterase inhibitors are less encouraging, with potential detrimental effects on the myocardium.

    Conclusions:

    • Adrenoceptor stimulation may be limited to acute CHF treatment.
    • The long-term efficacy and safety of phosphodiesterase inhibitors in CHF remain uncertain.
    • Further research is needed to establish the ultimate role of these agents in managing congestive heart failure.